What is the COVAX program?
-
The COVAX program is led by the vaccine alliance GAVI, the World Health Organisation(WHO) and the Coalition for Epidemic Preparedness Innovations(CEPI). The COVAX program is in partnership with UNICEF, vaccine manufacturers and the World Bank.
-
Aim: The COVAX program aims to ensure rapid, fair and equitable access to COVID-19 vaccines for all the countries around the world.
-
The COVAX program forms a key part of the Access to COVID-19 Tools(ACT) Accelerator.
-
Target: To vaccinate roughly 20% of the population in the 92 Advance Market Commitment (AMC) countries. This includes middle and lower-income nations that cannot afford to pay for COVID-19 vaccines.
-
Process of Vaccination: Once the vaccines receive approval, the vaccines will be bought by the COVAX facility. The COVAX facility will then try to provide it to the 20% population of each of the eligible countries at free of cost.
-
Funding: The funding target for this program for 2021 is about the US $6.8 billion. The funding is partly coming from high and middle-income countries that will also receive a share of the vaccines produced for COVAX.